{"name":"Cantero Therapeutics, a BridgeBio company","slug":"cantero-therapeutics-a-bridgebio-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2022-06-27","type":"trial","source":"GlobeNewswire","summary":"BridgeBio Pharma Announces Positive Phase 1 Data and Phase - GlobeNewswire","headline":"BridgeBio Pharma Announces Positive Phase 1 Data and Phase","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}